GAO – Policy & Medicine

GAO Adds HHS to High Risk List of Agencies that Need Transformation

GAO Report Indicates Providers Question MIPS Outcomes

GAO Releases Second Report Detailing Government Response to COVID-19

HHS Not Using New Authority to Hire Top Scientists at FDA and NIH

GAO Report Highlights 340B Contracting Practices

Senators Ask GAO to Investigate Potential Orphan Drug Act Abuse

New OIG Guidance on IRO Independence and Objectivity

GAO Issues Report on Generic Drug Price Increases

GAO Report Harshly Critical of Medicare Advantage Plans

E&C Subcommittee Hearing, HHS OIG and GAO Reports on Medicare and Medicaid Fraud Enforcement – More Work to Be Done